» Articles » PMID: 37841687

Glutamatergic Synaptic Deficits in the Prefrontal Cortex of the Ts65Dn Mouse Model for Down Syndrome

Overview
Journal Front Neurosci
Date 2023 Oct 16
PMID 37841687
Authors
Affiliations
Soon will be listed here.
Abstract

Down syndrome (DS), the most prevalent cause of intellectual disability, stems from a chromosomal anomaly resulting in an entire or partial extra copy of chromosome 21. This leads to intellectual disability and a range of associated symptoms. While there has been considerable research focused on the Ts65Dn mouse model of DS, particularly in the context of the hippocampus, the synaptic underpinnings of prefrontal cortex (PFC) dysfunction in DS, including deficits in working memory, remain largely uncharted territory. In a previous study featuring mBACtgDyrk1a mice, which manifest overexpression of the gene, a known candidate gene linked to intellectual disability and microcephaly in DS, we documented adverse effects on spine density, alterations in the molecular composition of synapses, and the presence of synaptic plasticity deficits within the PFC. The current study aimed to enrich our understanding of the roles of different genes in DS by studying Ts65Dn mice, which overexpress several genes including , to compare with our previous work on mBACtgDyrk1a mice. Through electrophysiological experiments, including patch-clamp and extracellular field potential recordings, we identified alterations in the intrinsic properties of PFC layer V/VI pyramidal neurons in Ts65Dn male mice. Additionally, we observed changes in the synaptic plasticity range. Notably, long-term depression was absent in Ts65Dn mice, while synaptic or pharmacological long-term potentiation remained fully expressed in these mice. These findings provide valuable insights into the intricate synaptic mechanisms contributing to PFC dysfunction in DS, shedding light on potential therapeutic avenues for addressing the neurocognitive symptoms associated with this condition.

Citing Articles

Analysis of microisolated frontal cortex excitatory layer III and V pyramidal neurons reveals a neurodegenerative phenotype in individuals with Down syndrome.

Alldred M, Pidikiti H, Ibrahim K, Lee S, Heguy A, Hoffman G Acta Neuropathol. 2024; 148(1):16.

PMID: 39105932 PMC: 11578391. DOI: 10.1007/s00401-024-02768-0.

References
1.
Mao R, Zielke C, Zielke H, Pevsner J . Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics. 2003; 81(5):457-67. DOI: 10.1016/s0888-7543(03)00035-1. View

2.
Pennington B, Moon J, Edgin J, Stedron J, Nadel L . The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev. 2003; 74(1):75-93. DOI: 10.1111/1467-8624.00522. View

3.
Hawley L, Prochaska F, Stringer M, Goodlett C, Roper R . Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes. Pharmacol Biochem Behav. 2022; 217:173404. PMC: 9516663. DOI: 10.1016/j.pbb.2022.173404. View

4.
Daoudal G, Hanada Y, Debanne D . Bidirectional plasticity of excitatory postsynaptic potential (EPSP)-spike coupling in CA1 hippocampal pyramidal neurons. Proc Natl Acad Sci U S A. 2002; 99(22):14512-7. PMC: 137914. DOI: 10.1073/pnas.222546399. View

5.
Volianskis A, France G, Jensen M, Bortolotto Z, Jane D, Collingridge G . Long-term potentiation and the role of N-methyl-D-aspartate receptors. Brain Res. 2015; 1621:5-16. PMC: 4563944. DOI: 10.1016/j.brainres.2015.01.016. View